Area of research
Oncology · Molecular Biology
Research interest
Research interests include Cancer research, Immunotherapy, Tumor microenvironment, Melanoma, Immune system, and Immune checkpoint.
Tumor Intrinsic METTL5 Modulates ATF4 Translation to Prevent T Cell‐Induced Ferroptosis in Ovarian Cancer
Development of a RIPK1 degrader to enhance antitumor immunity
Obesity Is Associated with Altered Tumor Metabolism in Metastatic Melanoma
9p21 loss confers a cold tumor immune microenvironment and primary resistance to immune checkpoint therapy
The Glutaminase Inhibitor CB-839 (Telaglenastat) Enhances the Antimelanoma Activity of T-Cell–Mediated Immunotherapies
Irreversible electroporation reverses resistance to immune checkpoint blockade in pancreatic cancer
A Novel Mitochondrial Inhibitor Blocks MAPK Pathway and Overcomes MAPK Inhibitor Resistance in Melanoma
Abstract 4152: Irreversible electroporation induces immunogenic cell death and mediates durable response in orthotopic PDAC model in combination with anti-PD-1
Abstract 4152: Irreversible electroporation induces immunogenic cell death and mediates durable response in orthotopic PDAC model in combination with anti-PD-1
Increased Tumor Glycolysis Characterizes Immune Resistance to Adoptive T Cell Therapy
CD38-Mediated Immunosuppression as a Mechanism of Tumor Cell Escape from PD-1/PD-L1 Blockade
The RNA-binding Protein MEX3B Mediates Resistance to Cancer Immunotherapy by Downregulating HLA-A Expression
Metabolic strategies of melanoma cells: Mechanisms, interactions with the tumor microenvironment, and therapeutic implications
Melanoma and immunotherapy bridge 2015
Loss of PTEN Promotes Resistance to T Cell–Mediated Immunotherapy